Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
- PMID: 39933779
- PMCID: PMC11815426
- DOI: 10.1136/bmjgast-2024-001593
Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
Abstract
Introduction: Chronic hepatitis C virus (HCV) infection is prevalent in prisons. Universal reception HCV testing is recommended, but acceptance can be suboptimal. To detect and treat missed HCV infections, a high-intensity test and treat (HITT) programme was introduced to rapidly test entire prisons. It remains unknown whether regular HITTs will be required to maintain prison microelimination. We aimed to assess the outcomes of HITTs conducted in a prison 4 years apart with ongoing reception testing.
Methods: A prospective observational evaluation of the impact of HITTs was conducted in January 2020 and February 2024 at Low Newton, a female prison. The outcomes of the reception testing were reviewed in the intervening period to determine the number of newly identified HCV infections.
Results: HITTs were successful in testing almost all residents (305/307) in 2020 and (296/296) in 2024. The number of newly diagnosed HCV individuals fell from 6.6% in 2020 to 0.3% in 2024. One new HCV case was identified in the second HITT. In between the HITTs, 89% of receptions had HCV testing, increasing from 83% in 2020 to 95% in 2023. Overall, 81% (144/178) of active HCV infections received antiviral treatment, and 89% achieved sustained virological response. The proportion of active HCV infections between the HITTs was 7.2% through reception testing.
Conclusion: A follow-up HITT after 4 years yielded only 0.3% active HCV infection in a high HCV prevalence prison and a reasonably good reception testing and treatment programme. Therefore, resources should be focused on optimising reception testing rather than undertaking repeated HITTs.
Keywords: ANTIVIRAL THERAPY; HEALTH SERVICE RESEARCH; HEPATITIS C.
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
Conflict of interest statement
Competing interests: SMcP has received consultancy/speakers fees from Abbvie, Allergan, BMS, Gilead, Intercept, MSD, Novo Nordisk, Norgine, Novartis and Sequana. The other authors have no competing interests.
Figures



Similar articles
-
Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.J Acquir Immune Defic Syndr. 2021 Dec 15;88(5):465-469. doi: 10.1097/QAI.0000000000002801. J Acquir Immune Defic Syndr. 2021. PMID: 34757974
-
A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.J Hepatol. 2023 Sep;79(3):635-644. doi: 10.1016/j.jhep.2023.04.019. Epub 2023 Apr 26. J Hepatol. 2023. PMID: 37116714 Clinical Trial.
-
An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.BMC Public Health. 2019 May 10;19(Suppl 3):466. doi: 10.1186/s12889-019-6783-4. BMC Public Health. 2019. PMID: 32326938 Free PMC article.
-
Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.Curr HIV/AIDS Rep. 2020 Feb;17(1):18-25. doi: 10.1007/s11904-019-00476-z. Curr HIV/AIDS Rep. 2020. PMID: 31933274 Review.
-
Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review.Int J Drug Policy. 2018 Jul;57:95-103. doi: 10.1016/j.drugpo.2018.04.003. Epub 2018 Apr 30. Int J Drug Policy. 2018. PMID: 29715590
References
-
- WHO Hepatitis C fact sheet. 2021. [20-Aug-2024]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c Available. Accessed.
-
- UKHSA Hepatitis C in the UK 2023. Working to eliminate hepatitis C as a public health threat. 2023
-
- WHO Global health sector strategy on viral hepatitis 2016-2021. 2016
-
- UKHSA Hepatitis C in England 2023: inforgraphic. 2023. https://assets.publishing.service.gov.uk/media/65b0e522f2718c000dfb1c20/... Available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources